Search the Newsreel

Stocks to watch: DBS, Keppel, CapitaLand Ascendas Reit, CapitaLand Ascott Trust, CAReit, CSE Global, Coliwoo

TerrAscend (OTC: TSNDF) posts Q2 2026 loss, adds debt and exits Michigan

Should CapitaLand Ascendas REIT’s New US and Spanish Logistics Buys Require Action From (SGX:A17U) Investors?

ASND Price Today: Ascendis Pharma A/S Stock Price, Quote & Chart | MEXC

This article provides current stock information for Ascendis Pharma A/S (ASND) on MEXC, detailing its live price, key market data like market cap and trading volume, and recent price performance. It also includes an FAQ section addressing common investor questions about the company's stock, …

Ascentage Pharma (AAPG) sets August 19 board meeting on results

Ascentage Pharma Group International (AAPG) has announced a board meeting scheduled for August 19, 2026. The main purpose of this meeting is to review and approve the company's unaudited interim results for the six months ending June 30, 2026, and to authorize their publication. …

CORRECTION: Ascentage Pharma to Report 2026 Six Month

Ascentage Pharma Group International has issued a correction regarding the timing of its 2026 Six Month Interim Results announcement and corporate update. The event will now take place at 7:00 am Eastern Daylight Time (EDT) on August 19, 2026, with an English language webcast …

Ascentage Pharma Schedules Chinese and English Webcasts Aug. 19-20

Ascentage Pharma announced it will release its unaudited six-month 2026 interim results and provide a corporate update on August 19, 2026, at 7:00 am EDT / 7:00 pm HKT. The company will host a Mandarin investor webcast on August 19, 2026, and an English …

CapitaLand Ascendas REIT 1H Net Property Income S$556.1M Vs. S$523.4M >A17U.SG

CapitaLand Ascendas REIT : Revenue, income, and AUM rose YoY, with strong acquisitions and stable leverage

Ascendis Pharma A/S

The article is a financial filing notification, specifically a Form 6K from Ascendis Pharma A/S, for April 8. It also includes general market data, news headlines, and stock performance figures, typical of a financial news platform.

Enterprise value to EBIT forward of Ascent Bridge Limited – SGX:AWG

Ascentage Pharma (NASDAQ: AAPG) names new CBO and CCO for global growth

Ascentage Pharma Group International has appointed Dr. Faiçal Miyara as Chief Business Officer and Jim Ziegler as Chief Commercial Officer to bolster its global expansion strategy. Dr. Miyara will lead global business development, while Mr. Ziegler will manage commercialization in the United States and …

Price to earnings forward of Ascent Bridge Limited – SGX:AWG

Ascentage Pharma Group International (NASDAQ:AAPG) Stock Price Down 4.6% - Here's Why

Ascent Bridge Limited Revenue Breakdown – SGX:AWG

Ascentage Pharma Appoints Dr. Faiçal Miyara as Chief Business Officer and Jim Ziegler as Chief Commercial Officer

Ascentage Pharma has announced the appointments of Dr. Faiçal Miyara as Chief Business Officer and Jim Ziegler as Chief Commercial Officer. These appointments aim to strengthen the company's global business development and establish a dedicated commercial organization in the United States. Both executives will …

Ascentage Pharma Group International - Unsponsored ADR (NASDAQ:AAPG) Receives Average Rating of "Buy" from Analysts

Ascentage Pharma Group Number of Employees 2026 | Employee Count & Headcount Data

Ascentage Pharma Group International Co., Ltd. (6855) has approximately 760 employees worldwide as of March 2026, marking a 19.2% growth since 2023. The company, headquartered in Suzhou, China, with major operations in China and the United States, is actively hiring, with 5 active job …

ASND News & Events

This page provides a comprehensive overview of recent news, events, and price alerts related to Ascendis Pharma (ASND). It includes various news articles detailing clinical trial data releases, index inclusions, and financial results. The events section highlights analyst notes and new data presentations for …

ASND Stock News Today | Earnings, Events & Price Alerts

Ascentage Pharma Group International Revenue Breakdown – HKEX:6855

Ascentage Pharma Group International (HKEX:6855) generated 638.92 million HKD last year, with its top-performing segment, Therapies for Hematological Malignancies, contributing 541.47 million HKD. The majority of this revenue, 622.65 million HKD, came from China. The article provides a breakdown of the company's revenue by …

Ascendis Pharma A/S (ASND) Institutional Confidence

Ascendis Pharma A/S (ASND) has an institutional shareholding score of 10.00, placing it first in the Biotechnology & Medical Research industry. The institutional shareholding proportion is 111.42%, a slight decrease of 4.32% quarter-over-quarter. ETHSX is the largest institutional shareholder, holding 132.15K shares, which represents …

Why TerrAscend Corp. stock surged yesterday

Ascentage Pharma (NASDAQ: AAPG) CEO ranks No.3 on Medicine Maker 2026 list

Ascentage Pharma's Chairman and CEO, Dr. Dajun Yang, has been recognized on The Medicine Maker Power List 2026, ranking No. 3 in the Small Molecules category. The list honors 60 global leaders driving innovation in drug discovery and development. Dr. Yang's inclusion highlights his …

Ascendis Pharma A/S (ASND) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis of Ascendis Pharma A/S (ASND), highlighting its current valuation score of 7.87 within the Biotechnology & Medical Research industry. It notes the P/E ratio is 36.18, which is below its recent high but significantly above its recent low. …

Ascendis Pharma A/S ADR Unsponsored Brazilian Depositary Receipt Repr 0.0666 ADR

This page provides financial information for Ascendis Pharma A/S ADR (A1SN34) traded on BMFBOVESPA. It focuses on the "Price to book forward" metric and lists the company's trading status as "Market closed" with "No trades." The content is primarily a financial data page from …

Ascendis Pharma A/S (ASND) Expected to Release Quarterly Earnings on Thursday

Ascendis Pharma A/S $ASND Stock Holdings Reduced by Tri Locum Partners LP

Empowered Funds LLC Acquires 14,438 Shares of Ascendis Pharma A/S $ASND

Ascendis Pharma A/S (ASND) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Ascendis Pharma A/S (ASND), focusing on its price momentum, support and resistance levels, and various technical indicators. The stock's current price momentum score is 3.21, ranking it low in the Biotechnology & Medical Research industry, and it …

Ascentage Pharma Group International (AAPG) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Ascentage Pharma Group International (AAPG), covering key indicators and moving averages. It details the current signals for MACD, RSI, KDJ, and others, showing a mix of neutral and sell signals, alongside various moving average values. The analysis …

Ascendis Pharma A/S (ASND) Financial Health: Profitability & Balance Sheet Analysis

Ascendis Pharma A/S (ASND) has a current financial score of 8.41, ranking 45 out of 385 in the Biotechnology & Medical Research industry, indicating stable financial status and high operating efficiency. The company's latest quarterly revenue surged by 153.66% year-over-year to $289.14 million, with …

Ascendis Pharma Number of Employees 2026 | Employee Count & Headcount Data

Ascendis Pharma A/S (NASDAQ: ASND) had 1,439 employees worldwide as of March 2026, marking a 49.3% growth since 2023. The company is actively hiring, with 186 job postings in 2026, and its workforce is primarily concentrated in Denmark, the United States, and Germany. The …

Ascentage Pharma Group International (AAPG) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides an overview of Ascentage Pharma Group International (AAPG), detailing its current stock price, market capitalization, and recent trading activity. It highlights the company's financial information, discussions, and analysis resources available on TradingKey, and emphasizes the general nature of the investment information …

Price-Driven Insight from (ASND) for Rule-Based Strategy

This article provides a price-driven insight for Ascendis Pharma A/s (ASND), highlighting divergent sentiment across all time horizons and an exceptional 27.2:1 risk-reward setup. It details institutional trading strategies, including long, breakout, and short positions, along with multi-timeframe signal analysis to guide potential trading …

Ascentage Pharma Group International (AAPG) Income Statement

This article provides key financial insights into Ascentage Pharma Group International (AAPG) through its income statement, offering both quarterly and annual data. It includes FAQs explaining how to interpret the income statement, distinguishing between quarterly and annual reports, and identifying the most critical metrics …